Efficacy of taxanes as adjuvant treatment of breast cancer: a review and meta-analysis of randomised clinical trials.
about
A Review of Paclitaxel and Novel Formulations Including Those Suitable for Use in DogsModel-based meta-analysis for quantifying Paclitaxel dose response in cancer patients.PTK7 as a potential prognostic and predictive marker of response to adjuvant chemotherapy in breast cancer patients, and resistance to anthracycline drugs.Apicidin and docetaxel combination treatment drives CTCFL expression and HMGB1 release acting as potential antitumor immune response inducers in metastatic breast cancer cells.The triterpenoid cucurbitacin B augments the antiproliferative activity of chemotherapy in human breast cancerCYP2C8*3 increases risk of neuropathy in breast cancer patients treated with paclitaxelReal-world impact of granulocyte-colony stimulating factor on febrile neutropeniaDelayed triggering of oestrogen induced apoptosis that contrasts with rapid paclitaxel-induced breast cancer cell death.Molecular-targeted nanotherapies in cancer: enabling treatment specificity.ADAM12-L confers acquired 5-fluorouracil resistance in breast cancer cellsAdjuvant taxane-based chemotherapy for early stage breast cancer: a real-world comparison of chemotherapy regimens in Ontario.Effectiveness of biosimilar filgrastim vs. original granulocyte colony-stimulating factors in febrile neutropenia prevention in breast cancer patients.
P2860
Q26801149-EE6FDBD6-E488-49ED-B2E7-DE7FF8E6AAE9Q33749066-19819F94-1EE0-4A1C-87DB-F8056EAADDB5Q34352797-198DB7E5-A648-435F-9384-B5BBFD8AF938Q36282754-7F421107-E34A-4B29-9359-9E70E5C6CE11Q36763291-23779383-AD2F-493D-A26C-91551C9C2F63Q36862832-5729C9EF-346F-4670-B3C1-5D75096AB777Q36897773-76BAA8A3-960C-429A-9B8F-26D2F2F107F0Q37650708-9EC33DE8-9CFB-4DC8-910C-EB90407278DEQ37954497-A4742765-6ECA-4AD7-92AB-439127BB8680Q41548025-5A1E03E2-D614-44BF-A143-E55DCD73CAB8Q41706289-E4B2B250-0C6B-4E1C-B5E7-E6BDBCE550FEQ47213188-478D42E7-6A03-43A6-9F5E-F18FE73515B3
P2860
Efficacy of taxanes as adjuvant treatment of breast cancer: a review and meta-analysis of randomised clinical trials.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Efficacy of taxanes as adjuvan ...... of randomised clinical trials.
@en
Efficacy of taxanes as adjuvan ...... of randomised clinical trials.
@nl
type
label
Efficacy of taxanes as adjuvan ...... of randomised clinical trials.
@en
Efficacy of taxanes as adjuvan ...... of randomised clinical trials.
@nl
prefLabel
Efficacy of taxanes as adjuvan ...... of randomised clinical trials.
@en
Efficacy of taxanes as adjuvan ...... of randomised clinical trials.
@nl
P2093
P2860
P1476
Efficacy of taxanes as adjuvan ...... of randomised clinical trials.
@en
P2093
Clara Martorell
Eliazar Sabater
Jordi Ginés
Marta Monroy
Miguel A Casado
P2860
P2888
P304
P356
10.1007/S12094-011-0686-X
P50
P577
2011-07-01T00:00:00Z